Sarpogrelate Hydrochloride Extended Release Tablet 300mg

Adult dose

Adults: Sarpogrelate Hydrochloride extended-release tablet 300mg should be taken orally once daily after a meal. It should not be chewed or crushed but taken as a whole.

This medication should not be used in patients with bleeding conditions. This is because bleeding may worsen in conditions with a high risk of bleeding, such as hemophilia and gastric ulcers. Women who are pregnant or may become pregnant should not take this medication due to the risk of harm to the fetus. Women during menstruation or patients with a tendency to bleed, as well as those taking anticoagulants or antiplatelet agents, should use this medication with caution. The risk of bleeding may increase. Patients with severely impaired renal function or the elderly should be cautious when using this medication, as drug excretion may be affected. When taking this medication, various side effects such as urticaria, dyspepsia, diarrhea, headache, cough, etc., may occur, so it is important to observe symptoms closely. In particular, serious side effects such as bleeding, blood disorders, and liver function abnormalities may occur, so any unusual symptoms should be reported to medical personnel immediately. Regular blood tests are recommended during the use of this medication to detect adverse reactions early. When taking this medication with anticoagulants or antiplatelet agents, the risk of bleeding may increase, so care should be taken during co-administration. It is advisable for pregnant or breastfeeding women to avoid this medication, and if it is absolutely necessary, they should consult a healthcare professional and avoid breastfeeding. Safety in children has not been established, so it is safer not to use this medication in children. This medication should be kept out of the reach of children, and transferring it to other containers is not advisable as it may compromise the quality.

Serious side effects

Urticaria, bleeding (gastrointestinal bleeding, intracranial bleeding, subcutaneous bleeding), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, hematemesis, melena, intracranial hemorrhage, liver cirrhosis, angina pectoris, myocardial infarction, cerebral infarction, stroke, fractures, gastric perforation, intestinal obstruction, worsening of Crohn's disease, diabetic foot ulcer, gallbladder cancer, chest pain, peripheral edema, pneumonia, pyelonephritis, soft tissue infection, increased blood pressure, dyspnea, chest pain, paralysis, severe

Mild side effects

• Nasopharyngitis
• conjunctivitis
• upper respiratory tract infection
• dyspepsia
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• decreased appetite

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius at room temperature to maintain the drug's efficacy for a longer period.

Appearance

White rectangular extended-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle